Original news and analysis on international IP policy
After some five years of negotiations, the World Trade Organization (WTO) free-trade talks were halted today as ministers of key countries left the negotiating table. But key intellectual property issues will be kept on the table for whenever they return,…
The United Kingdom Patent Office should be replaced by an institution with the same power and responsibility that it has today but with an extra duty to also serve the public interest, a group of intellectual property experts has proposed.…
This week’s Group of Eight (G8) meeting in Saint Petersburg, Russia highlighted piracy and counterfeiting as one area in which G8 is determined to step up its effort, but it also made commitments to improve access to medicines for infectious…
BRUSSELS – A majority of the 400 selected participants at a recent European Commission hearing on the future patent policy in Europe called for more centralisation – in the form of a single patent system or a common litigation system…
Kamil Idris, Director General de la Organización Mundial de la Propiedad Intelectual, ha procedido a rectificar su edad, registrada desde hace 20 años en la OMPI, creando todo tipo de especulación de que ganaría inmensamente con el cambio. Más aún,…
Por Tove Iren S. Gerhardsen Mustafa Pulat, Consejero de la Misión Permanente de Turquía en Ginebra, dejará su cargo a mediados de agosto. Se incorporó a la misión en 2002, donde se ocupa de cuestiones relacionadas con la Organización Mundial…
Atul Kaushik is in his last week of work as first secretary (legal) of the Permanent Mission of India to the World Trade Organization (WTO) in Geneva this week (week of 10 July). Kaushik, who has played a major role…
BRUSSELS – The European Commissioner for Internal Market and Services, Charlie McCreevy, this week said he will pay “particular attention” to intellectual property rights during the coming year, including one last drive to create a European Community patent. “I will…
BRUSSELS – The European Commission today fined Microsoft €280.5 million ($356.35 million) for failing to comply with a 2004 Commission request to provide documents that would make it easier for other companies to develop products that would be interoperable with…
A monopoly by a single pharmaceutical company on a new medicine for HIV/AIDS has limited access to the medicine to a select group of patients in developing countries, a non-profit group said today. The product is lopinavir/ritonavir (Kaletra) and is…